Pardo Geoffrey B
SEC insider (Form 3/4/5 filer). CIK 0001753143. Director at SpyGlass Pharma, Inc. (SGP) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Feb 9, 2026. Located in ALISO VIEJO, CA.
Companies Pardo Geoffrey B has filed insider reports for
- SpyGlass Pharma, Inc. (SGP): Director
- SHOULDER INNOVATIONS, INC. (SI): Director, 10% Owner
Pardo Geoffrey B
CIK: 0001753143
Transaction Breakdown
Open Market Buys (P)2 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)2 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Feb 9, 2026SGP
SpyGlass Pharma, Inc.
ConversionIndirect1.9M shares- - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
PurchaseIndirect312.5K shares at avg. $16.00$5.0M - Feb 5, 2026SGP
SpyGlass Pharma, Inc.
AwardDirectStock Option (right to buy)
27.4K shares- - Aug 1, 2025SI
SHOULDER INNOVATIONS, INC.
ConversionIndirect2.3M shares- - Aug 1, 2025SI
SHOULDER INNOVATIONS, INC.
PurchaseIndirect100K shares at avg. $15.00$1.5M - Aug 1, 2025SI
SHOULDER INNOVATIONS, INC.
AwardDirect7.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 9, 2026 |  SGP SpyGlass Pharma, Inc. | Conversion | 1,875,013 | - | $0 | Indirect |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | Purchase | 312,500 | $16.00 | $5,000,000 | Indirect |
| Feb 5, 2026 | SGP SpyGlass Pharma, Inc. | Award Stock Option (right to buy) | 27,400 | - | - | Direct |
| Aug 1, 2025 |  SI SHOULDER INNOVATIONS, INC. | Conversion | 2,280,482 | - | - | Indirect |
| Aug 1, 2025 | SI SHOULDER INNOVATIONS, INC. | Purchase | 100,000 | $15.00 | $1,500,000 | Indirect |
| Aug 1, 2025 | SI SHOULDER INNOVATIONS, INC. | Award | 7,666 | - | - | Direct |
1-6 of 6 transactions